Akebia Therapeutics Inc. buy BTIG Research
Start price
25.02.26
/
50%
€1.08
Target price
25.02.27
€3.39
Performance (%)
-0.56%
Price
08:47
?
Summary
This prediction is currently active. The BUY prediction by BTIG_Research for Akebia Therapeutics Inc. is nearly unchanged. This prediction currently runs until 25.02.27. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Akebia Therapeutics Inc. | -0.56% |
| iShares Core DAX® | -0.383% |
| iShares Nasdaq 100 | -0.411% |
| iShares Nikkei 225® | 1.838% |
| iShares S&P 500 | -0.712% |
Comments by BTIG_Research for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics (AKBA) had its price target lowered by BTIG Research from $5.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for AKBA provided by MarketBeat
Stopped prediction by BTIG_Research for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.27
02.12.25
02.12.25
€4.31
02.12.26
02.12.26
-16.01%
08:47
08:47
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.93
29.10.25
29.10.25
€4.29
29.10.26
29.10.26
-44.50%
08:47
08:47
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.92
29.11.23
29.11.23
€3.64
29.11.24
29.11.24
122.78%
30.11.24
30.11.24